Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,166 papers from all fields of science
Search
Sign In
Create Free Account
KB 2796
Known as:
KB-2796
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
lomerizine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia.
V. Danielisová
,
M. Chavko
Experimental Neurology
1998
Corpus ID: 27046331
NMDA receptor antagonists have been demonstrated to be neuroprotective in focal cerebral ischemia and are supposed to prevent…
Expand
1997
1997
Effects of KB-2796 on plasma extravasation following antidromic trigeminal stimulation in the rat.
M. Hashimoto
,
Y. Yamamoto
,
H. Takagi
Research Communications in Molecular Pathology…
1997
Corpus ID: 25547069
We investigated the effects of KB-2796 (1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride), a…
Expand
1994
1994
KB-2796, a calcium channel blocker, ameliorates ischemic spinal cord damage in rabbits
V. Danielisová
,
M. Chavko
Neurochemical Research
1994
Corpus ID: 11590257
The effect of the calcium channel blocker (KB-2796) on metabolic and functional recovery in rabbit spinal cord after 20, 30, and…
Expand
1994
1994
[The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].
Y. Fujishima
,
H. Hara
,
M. Shimazawa
,
K. Yokota
,
T. Sukamoto
Nihon yakurigaku zasshi. Folia pharmacologica…
1994
Corpus ID: 22595369
The effects of KB-2796, a new Ca(2+)-channel blocker, on 5-hydroxytryptamine (5-HT)-induced responses were investigated in…
Expand
1993
1993
Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.
H. Hara
,
K. Yokota
,
M. Shimazawa
,
T. Sukamoto
Japanese Journal of Pharmacology
1993
Corpus ID: 25089233
The effects of the novel calcium channel antagonist KB-2796, other calcium channel antagonists, an N-methyl-D-aspartate (NMDA…
Expand
1992
1992
[Hemorheological effect of KB-2796, a new Ca2+ antagonist].
N. Yamamoto
,
K. Yokota
,
A. Ikegami
,
A. Yamashita
,
K. Ito
Nihon yakurigaku zasshi. Folia pharmacologica…
1992
Corpus ID: 8903647
The hemorheological effect of KB-2796, 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4,-trimethoxybenzyl)piperazine dihydrochloride, was…
Expand
1990
1990
Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia.
H. Hara
,
A. Ozaki
,
M. Yoshidomi
,
T. Sukamoto
Archives internationales de pharmacodynamie et de…
1990
Corpus ID: 29777051
The protective effect of KB-2796, a new calcium antagonist possessing a selective vasodilator activity on cerebral vessels in…
Expand
1990
1990
Age-related changes in the uptake of calcium channel blockers by brain capillary endothelial cells and synaptosomal fractions
H. Waki
,
K. Kon
,
Yasukazu Tanaka
,
S. Ando
Neuroscience Letters
1990
Corpus ID: 33181281
1989
1989
Benzylpiperazine derivatives. XI. Synthesis of compounds related to the metabolites of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride (KB-2796).
H. Ohtaka
,
M. Hori
,
R. Iemura
,
H. Yumioka
Chemical and pharmaceutical bulletin
1989
Corpus ID: 23608221
The metabolites of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride (KB-2796, 1), a cerebral…
Expand
1986
1986
Effects of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, a new synthesized Ca2+ blocker KB-2796, on free fatty acid liberation in ischemic brain in rats.
T. Kanazawa
,
M. Kidooka
,
M. Matsuda
,
J. Handa
Nihon geka hokan. Archiv fur japanische Chirurgie
1986
Corpus ID: 45288851
Effects of 1-[bis(4-fluorophenyl)methyl]-4-(2, 3, 4trimethoxybenzyl) piperazine dihydrochloride, a New Synthesized Ca2+ Blocker…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE